Summary:
Clinical Research Study - Type 2 Diabetes
A 22-week research study is evaluating if a new investigational insulin can provide effective and consistent blood sugar control in people with type 2 diabetes.
Qualified Participants Must:
• Be 18 years of age or age or older
•
Have taken insulin for at least 12 weeks
•
Have had a diagnosis of type 2 diabetes for at least 24 weeks
•
Have taken an unchanged dose of Oral Antidiabetic Drugs (OAD) for at least 12 week
•
Have an HbA1c level between 7.0-10.0%
•
Have a BMI of 45 kg/m2 or less
Qualified Participants May Receive:
All study related care and study medication at no cost and may be compensated for travel.